Sergey Voloshin
2PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|May 07, 2025
Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL.Michael J Mauro, Yosuke Minami, Andreas Hochhaus
|Aug 18, 2021
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.Delphine Réa, Michael J Mauro, Carla Boquimpani
Pageof 1
Frequent Collaborators
2 joint publications
Delphine Réa
2 joint publications
Michael J Mauro
2 joint publications
Elza Lomaia
2 joint publications
Jane F Apperley
2 joint publications
Andre Abdo
2 joint publications
Susanne Saussele
2 joint publications
Mario Annunziata
2 joint publications
Naeem Chaudhri
2 joint publications
Koji Sasaki
2 joint publications
Lynette Chee
